PepGen Inc.
General ticker "PEPG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $139.1M (TTM average)
PepGen Inc. follows the US Stock Market performance with the rate: 10.1%.
Estimated limits based on current volatility of 2.8%: low 1.43$, high 1.51$
Factors to consider:
- Total employees count: 81 as of 2024
- Top business risk factors: Limited operating history, Regulatory and compliance, Strategic risks and growth management, Geopolitical risks, Acquisition/divestiture risks
- Current price 49.8% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.83$, 8.56$]
- 2026-12-31 to 2027-12-31 estimated range: [1.90$, 5.93$]
Financial Metrics affecting the PEPG estimates:
- Negative: with PPE of -2.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term PEPG quotes
Long-term PEPG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $84.77MM | $97.74MM | $93.61MM |
| Operating Income | $-84.77MM | $-97.74MM | $-93.61MM |
| Non-Operating Income | $6.21MM | $7.14MM | $4.01MM |
| R&D Expense | $68.13MM | $76.48MM | $71.04MM |
| Income(Loss) | $-78.55MM | $-90.60MM | $-89.61MM |
| Taxes | $0.07MM | $-0.62MM | $0.05MM |
| Net Income(Loss)* | $-78.63MM | $-89.98MM | $-89.66MM |
| Stockholders Equity | $108.42MM | $118.62MM | $147.44MM |
| Assets | $143.05MM | $150.88MM | $173.91MM |
| Operating Cash Flow | $-69.00MM | $-82.37MM | $-81.64MM |
| Capital expenditure | $2.60MM | $0.50MM | $0.26MM |
| Investing Cash Flow | $-32.00MM | $-37.67MM | $-15.23MM |
| Financing Cash Flow | $-0.19MM | $88.75MM | $107.98MM |
| Earnings Per Share** | $-3.30 | $-2.85 | $-2.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.